Summary

Executive Summay

Azoth Analytics has released a research report titled “Global Prostate Care Market (2026 Edition)” which provides a complete analysis of the Global Prostate Care industry in terms of market segmentation By Treatment Type (Medications, Surgical Treatments, Minimally Invasive Therapies, and Radiation Therapy), By Disease Type (Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Prostatitis), By End-User (Hospitals & Clinics, Specialty Urology Centers, Home Care Settings).

The report analyses the Prostate Care Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Brazil, Germany, United Kingdom, France, Italy, China, Japan, and India).The Global Prostate Care Market is operating within a dynamic and evolving healthcare ecosystem, driven by demographic shifts, technological innovations, and a growing awareness of men’s health issues. The market primarily focuses on the prevention, diagnosis, and treatment of prostate-related conditions such as Benign Prostatic Hyperplasia (BPH), Prostate Cancer, and Prostatitis, which are increasingly prevalent, particularly among the aging male population. With prostate cancer being one of the most common cancers among men worldwide, the demand for advanced screening tools, targeted therapies, and personalized treatment regimens continues to rise.

One of the key operational strengths of the market lies in the integration of multidisciplinary care approaches and technological advancements. Diagnostic innovations such as Prostate-Specific Antigen (PSA) tests, MRI fusion biopsies, and genomic testing have significantly improved early detection and risk stratification. Simultaneously, therapeutic advancements—ranging from robot-assisted laparoscopic prostatectomy and minimally invasive procedures like UroLift and Rezūm therapy, to cutting-edge radiation therapies like brachytherapy and intensity-modulated radiation therapy (IMRT)—are shaping a more patient-centered and outcome-driven market. Pharmaceutical advancements, including androgen deprivation therapy (ADT), chemotherapy, and immunotherapies, are offering more targeted and tolerable treatment options.

From an operational perspective, hospitals, urology centers, and specialty clinics form the backbone of service delivery. These healthcare providers are increasingly adopting value-based care models, supported by real-world evidence and electronic health records, which enhance patient tracking, follow-ups, and clinical outcomes. In parallel, home care settings are emerging as a viable alternative for chronic management and post-surgical recovery, fueled by telehealth adoption and patient preference for convenience and privacy.

The market is growing at a robust pace due to a combination of macroeconomic and societal factors. The global increase in life expectancy, rising incidence of lifestyle-related health issues, and greater emphasis on preventive healthcare are expanding the target patient base. Moreover, healthcare reforms, especially in developing regions, are improving access to diagnostic services and prostate treatments. Countries like the U.S., Germany, China, and Japan are leading the charge with significant investments in healthcare infrastructure, screening programs, and public awareness campaigns.

Commercially, the market is witnessing heightened competition among leading players such as Medtronic plc, Johnson & Johnson, Boston Scientific Corporation, and Abbott Laboratories, all of whom are focusing on product innovation, clinical trials, mergers and acquisitions, and strategic partnerships to strengthen their market positions. Digital health tools, including mobile health apps, AI-driven diagnostic platforms, and remote monitoring systems, are also being integrated into prostate care strategies, signaling a move toward precision medicine and digital therapeutics.

ページTOPに戻る

Table of Contents

Table of Contents



1. Market Background

1.1 Scope and Product Outlook

1.2 Executive Summary

1.3 Research Methodology



2. Analyst Recommendations

2.1 Invest in Early Detection and Screening Innovations

2.2 Expand Access Through Telehealth and Remote Monitoring



3. Global Prostate Care Market: Historic and Forecast

3.1 Impact Analysis of Macro Economic Factors on Global Prostate Care Market

3.2 Global Prostate Care Market: Dashboard

3.3 Global Prostate Care Market: Market Size and CAGR, 2021-2031 (USD Billion & CAGR)

3.4 Global Prostate Care Market: Market Value Assessment

3.5 Global Prostate Care Market Segmentation: By Treatment Type

3.5.1 Global Prostate Care Market, By Treatment Type Overview

3.5.2 Global Prostate Care Market Attractiveness Index, By Treatment Type

3.5.3 Global Prostate Care Market Size, By Medications, By Value, 2021H-2031F (USD Billion & CAGR)

3.5.4 Global Prostate Care Market Size, By Surgical Treatments, By Value, 2021H-2031F (USD Billion & CAGR)

3.5.5 Global Prostate Care Market Size, By Minimally Invasive Therapies, By Value, 2021H-2031F (USD Billion & CAGR)

3.5.6 Global Prostate Care Market Size, By Radiation Therapy, By Value, 2021H-2031F (USD Billion & CAGR)

3.6 Global Prostate Care Market Segmentation: By Disease Type

3.6.1 Global Prostate Care Market, By Disease Type Overview

3.6.2 Global Prostate Care Market Attractiveness Index, By Disease Type

3.6.3 Global Prostate Care Market Size, By Benign Prostatic Hyperplasia (BPH), By Value, 2021H-2031F (USD Billion & CAGR)

3.6.4 Global Prostate Care Market Size, By Prostate Cancer, By Value, 2021H-2031F (USD Billion & CAGR)

3.6.5 Global Prostate Care Market Size, By Prostatitis, By Value, 2021H-2031F (USD Billion & CAGR)

3.7 Global Prostate Care Market Segmentation: By End-User

3.7.1 Global Prostate Care Market, By End-User Overview

3.7.2 Global Prostate Care Market Attractiveness Index, By End-User

3.7.3 Global Prostate Care Market Size, By Hospitals & Clinics, By Value, 2021H-2031F (USD Billion & CAGR)

3.7.4 Global Prostate Care Market Size, By Specialty Urology Centers, By Value, 2021H-2031F (USD Billion & CAGR)

3.7.5 Global Prostate Care Market Size, By Home Care Settings, By Value, 2021H-2031F (USD Billion & CAGR)



4. Prostate Care Market, Region Analysis

4.1 Regional Coverage of the Study

4.2 Regional Snapshot



5. Americas Prostate Care Market: Historic and Forecast

5.1 Americas Prostate Care Market: Snapshot

5.2 Americas Prostate Care Market: Market Size and CAGR, 2021-2031 (USD Billion & CAGR)

5.3 Americas Prostate Care Market: Key Factors

5.4 Americas Prostate Care Market: Segment Analysis

5.5 Americas Prostate Care Market Segmentation: By Treatment Type

5.5.1 Americas Prostate Care Market, By Treatment Type Overview

5.5.2 Americas Prostate Care Market Size, By Medications, By Value, 2021H-2031F (USD Billion & CAGR)

5.5.3 Americas Prostate Care Market Size, By Surgical Treatments, By Value, 2021H-2031F (USD Billion & CAGR)

5.5.4 Americas Prostate Care Market Size, By Minimally Invasive Therapies, By Value, 2021H-2031F (USD Billion & CAGR)

5.5.5 Americas Prostate Care Market Size, By Radiation Therapy, By Value, 2021H-2031F (USD Billion & CAGR)

5.6 Americas Prostate Care Market Segmentation: By Disease Type

5.6.1 Americas Prostate Care Market, By Disease Type Overview

5.6.2 Americas Prostate Care Market Size, By Benign Prostatic Hyperplasia (BPH), By Value, 2021H-2031F (USD Billion & CAGR)

5.6.3 Americas Prostate Care Market Size, By Prostate Cancer, By Value, 2021H-2031F (USD Billion & CAGR)

5.6.4 Americas Prostate Care Market Size, By Prostatitis, By Value, 2021H-2031F (USD Billion & CAGR)

5.7 Americas Prostate Care Market Segmentation: By End-User

5.7.1 Americas Prostate Care Market, By End-User Overview

5.7.2 Americas Prostate Care Market Size, By Hospitals & Clinics, By Value, 2021H-2031F (USD Billion & CAGR)

5.7.3 Americas Prostate Care Market Size, By Specialty Urology Centers, By Value, 2021H-2031F (USD Billion & CAGR)

5.7.4 Americas Prostate Care Market Size, By Home Care Settings, By Value, 2021H-2031F (USD Billion & CAGR)

5.8 Americas Prostate Care Market Segmentation: By Country

5.8.1 Americas Prostate Care Market, By Country Overview

5.8.2 United States Prostate Care Market: Market Size and CAGR, 2021-2031 (USD Billion & CAGR)

5.8.2.1 United States Prostate Care Market, By Treatment Type

5.8.2.2 United States Prostate Care Market, By Disease Type

5.8.2.3 United States Prostate Care Market, By End-User

5.8.3 Canada Prostate Care Market: Market Size and CAGR, 2021-2031 (USD Billion & CAGR)

5.8.3.1 Canada Prostate Care Market, By Treatment Type

5.8.3.2 Canada Prostate Care Market, By Disease Type

5.8.3.3 Canada Prostate Care Market, By End-User

5.8.4 Brazil Prostate Care Market: Market Size and CAGR, 2021-2031 (USD Billion & CAGR)

5.8.4.1 Brazil Prostate Care Market, By Treatment Type

5.8.4.2 Brazil Prostate Care Market, By Disease Type

5.8.4.3 Brazil Prostate Care Market, By End-User

5.8.5 Rest of Americas Prostate Care Market: Market Size and CAGR, 2021-2031 (USD Billion & CAGR)

5.8.5.1 Rest of Americas Prostate Care Market, By Treatment Type

5.8.5.2 Rest of Americas Prostate Care Market, By Disease Type

5.8.5.3 Rest of Americas Prostate Care Market, By End-User



6. Europe Prostate Care Market: Historic and Forecast

6.1 Europe Prostate Care Market: Snapshot

6.2 Europe Prostate Care Market: Market Size and CAGR, 2021-2031 (USD Billion & CAGR)

6.3 Europe Prostate Care Market: Key Factors

6.4 Europe Prostate Care Market: Segment Analysis

6.5 Europe Prostate Care Market Segmentation: By Treatment Type

6.5.1 Europe Prostate Care Market, By Treatment Type Overview

6.5.2 Europe Prostate Care Market Size, By Medications, By Value, 2021H-2031F (USD Billion & CAGR)

6.5.3 Europe Prostate Care Market Size, By Surgical Treatments, By Value, 2021H-2031F (USD Billion & CAGR)

6.5.4 Europe Prostate Care Market Size, By Minimally Invasive Therapies, By Value, 2021H-2031F (USD Billion & CAGR)

6.5.5 Europe Prostate Care Market Size, By Radiation Therapy, By Value, 2021H-2031F (USD Billion & CAGR)

6.6 Europe Prostate Care Market Segmentation: By Disease Type

6.6.1 Europe Prostate Care Market, By Disease Type Overview

6.6.2 Europe Prostate Care Market Size, By Benign Prostatic Hyperplasia (BPH), By Value, 2021H-2031F (USD Billion & CAGR)

6.6.3 Europe Prostate Care Market Size, By Prostate Cancer, By Value, 2021H-2031F (USD Billion & CAGR)

6.6.4 Europe Prostate Care Market Size, By Prostatitis, By Value, 2021H-2031F (USD Billion & CAGR)

6.7 Europe Prostate Care Market Segmentation: By End-User

6.7.1 Europe Prostate Care Market, By End-User Overview

6.7.2 Europe Prostate Care Market Size, By Hospitals & Clinics, By Value, 2021H-2031F (USD Billion & CAGR)

6.7.3 Europe Prostate Care Market Size, By Specialty Urology Centers, By Value, 2021H-2031F (USD Billion & CAGR)

6.7.4 Europe Prostate Care Market Size, By Home Care Settings, By Value, 2021H-2031F (USD Billion & CAGR)

6.8 Europe Prostate Care Market Segmentation: By Country

6.8.1 Europe Prostate Care Market, By Country Overview

6.8.2 Germany Prostate Care Market: Market Size and CAGR, 2021-2031 (USD Billion & CAGR)

6.8.2.1 Germany Prostate Care Market, By Treatment Type

6.8.2.2 Germany Prostate Care Market, By Disease Type

6.8.2.3 Germany Prostate Care Market, By End-User

6.8.3 United Kingdom Prostate Care Market: Market Size and CAGR, 2021-2031 (USD Billion & CAGR)

6.8.3.1 United Kingdom Prostate Care Market, By Treatment Type

6.8.3.2 United Kingdom Prostate Care Market, By Disease Type

6.8.3.3 United Kingdom Prostate Care Market, By End-User

6.8.4 France Prostate Care Market: Market Size and CAGR, 2021-2031 (USD Billion & CAGR)

6.8.4.1 France Prostate Care Market, By Treatment Type

6.8.4.2 France Prostate Care Market, By Disease Type

6.8.4.3 France Prostate Care Market, By End-User

6.8.5 Italy Prostate Care Market: Market Size and CAGR, 2021-2031 (USD Billion & CAGR)

6.8.5.1 Italy Prostate Care Market, By Treatment Type

6.8.5.2 Italy Prostate Care Market, By Disease Type

6.8.5.3 Italy Prostate Care Market, By End-User

6.8.6 Rest of Europe Prostate Care Market: Market Size and CAGR, 2021-2031 (USD Billion & CAGR)

6.8.6.1 Rest of Europe Prostate Care Market, By Treatment Type

6.8.6.2 Rest of Europe Prostate Care Market, By Disease Type

6.8.6.3 Rest of Europe Prostate Care Market, By End-User



7. Asia Pacific Prostate Care Market: Historic and Forecast

7.1 Asia Pacific Prostate Care Market: Snapshot

7.2 Asia Pacific Prostate Care Market: Market Size and CAGR, 2021-2031 (USD Billion & CAGR)

7.3 Asia Pacific Prostate Care Market: Key Factors

7.4 Asia Pacific Prostate Care Market: Segment Analysis

7.5 Asia Pacific Prostate Care Market Segmentation: By Treatment Type

7.5.1 Asia Pacific Prostate Care Market, By Treatment Type Overview

7.5.2 Asia Pacific Prostate Care Market Size, By Medications, By Value, 2021H-2031F (USD Billion & CAGR)

7.5.3 Asia Pacific Prostate Care Market Size, By Surgical Treatments, By Value, 2021H-2031F (USD Billion & CAGR)

7.5.4 Asia Pacific Prostate Care Market Size, By Minimally Invasive Therapies, By Value, 2021H-2031F (USD Billion & CAGR)

7.5.5 Asia Pacific Prostate Care Market Size, By Radiation Therapy, By Value, 2021H-2031F (USD Billion & CAGR)

7.6 Asia Pacific Prostate Care Market Segmentation: By Disease Type

7.6.1 Asia Pacific Prostate Care Market, By Disease Type Overview

7.6.2 Asia Pacific Prostate Care Market Size, By Benign Prostatic Hyperplasia (BPH), By Value, 2021H-2031F (USD Billion & CAGR)

7.6.3 Asia Pacific Prostate Care Market Size, By Prostate Cancer, By Value, 2021H-2031F (USD Billion & CAGR)

7.6.4 Asia Pacific Prostate Care Market Size, By Prostatitis, By Value, 2021H-2031F (USD Billion & CAGR)

7.7 Asia Pacific Prostate Care Market Segmentation: By End-User

7.7.1 Asia Pacific Prostate Care Market, By End-User Overview

7.7.2 Asia Pacific Prostate Care Market Size, By Hospitals & Clinics, By Value, 2021H-2031F (USD Billion & CAGR)

7.7.3 Asia Pacific Prostate Care Market Size, By Specialty Urology Centers, By Value, 2021H-2031F (USD Billion & CAGR)

7.7.4 Asia Pacific Prostate Care Market Size, By Home Care Settings, By Value, 2021H-2031F (USD Billion & CAGR)

7.8 Asia Pacific Prostate Care Market Segmentation: By Country

7.8.1 Asia Pacific Prostate Care Market, By Country Overview

7.8.2 China Prostate Care Market: Market Size and CAGR, 2021-2031 (USD Billion & CAGR)

7.8.2.1 China Prostate Care Market, By Treatment Type

7.8.2.2 China Prostate Care Market, By Disease Type

7.8.2.3 China Prostate Care Market, By End-User

7.8.3 Japan Prostate Care Market: Market Size and CAGR, 2021-2031 (USD Billion & CAGR)

7.8.3.1 Japan Prostate Care Market, By Treatment Type

7.8.3.2 Japan Prostate Care Market, By Disease Type

7.8.3.3 Japan Prostate Care Market, By End-User

7.8.4 India Prostate Care Market: Market Size and CAGR, 2021-2031 (USD Billion & CAGR)

7.8.4.1 India Prostate Care Market, By Treatment Type

7.8.4.2 India Prostate Care Market, By Disease Type

7.8.4.3 India Prostate Care Market, By End-User

7.8.5 Rest of Asia Pacific Prostate Care Market: Market Size and CAGR, 2021-2031 (USD Billion & CAGR)

7.8.5.1 Rest of Asia Pacific Prostate Care Market, By Treatment Type

7.8.5.2 Rest of Asia Pacific Prostate Care Market, By Disease Type

7.8.5.3 Rest of Asia Pacific Prostate Care Market, By End-User



8. Middle East & Africa Prostate Care Market: Historic and Forecast

8.1 Middle East & Africa Prostate Care Market: Snapshot

8.2 Middle East & Africa Prostate Care Market: Market Size and CAGR, 2021-2031 (USD Billion & CAGR)

8.3 Middle East & Africa Prostate Care Market: Key Factors

8.4 Middle East and Africa Prostate Care Market: Segment Analysis

8.5 Middle East & Africa Prostate Care Market Segmentation: By Treatment Type

8.5.1 Middle East & Africa Prostate Care Market, By Treatment Type Overview

8.5.2 Middle East & Africa Prostate Care Market Size, By Medications, By Value, 2021H-2031F (USD Billion & CAGR)

8.5.3 Middle East & Africa Prostate Care Market Size, By Surgical Treatments, By Value, 2021H-2031F (USD Billion & CAGR)

8.5.4 Middle East & Africa Prostate Care Market Size, By Minimally Invasive Therapies, By Value, 2021H-2031F (USD Billion & CAGR)

8.5.5 Middle East & Africa Prostate Care Market Size, By Radiation Therapy, By Value, 2021H-2031F (USD Billion & CAGR)

8.6 Middle East & Africa Prostate Care Market Segmentation: By Disease Type

8.6.1 Middle East & Africa Prostate Care Market, By Disease Type Overview

8.6.2 Middle East & Africa Prostate Care Market Size, By Benign Prostatic Hyperplasia (BPH), By Value, 2021H-2031F (USD Billion & CAGR)

8.6.3 Middle East & Africa Prostate Care Market Size, By Prostate Cancer, By Value, 2021H-2031F (USD Billion & CAGR)

8.6.4 Middle East & Africa Prostate Care Market Size, By Prostatitis, By Value, 2021H-2031F (USD Billion & CAGR)

8.7 Middle East & Africa Prostate Care Market Segmentation: By End-User

8.7.1 Middle East & Africa Prostate Care Market, By End-User Overview

8.7.2 Middle East & Africa Prostate Care Market Size, By Hospitals & Clinics, By Value, 2021H-2031F (USD Billion & CAGR)

8.7.3 Middle East & Africa Prostate Care Market Size, By Specialty Urology Centers, By Value, 2021H-2031F (USD Billion & CAGR)

8.7.4 Middle East & Africa Prostate Care Market Size, By Home Care Settings, By Value, 2021H-2031F (USD Billion & CAGR)



9. Competitive Positioning

9.1 Companies’ Product Positioning

9.2 Market Share Analysis of Prostate Care Market

9.3 Company Profiles

9.3.1 Abbott Laboratories

9.3.2 AstraZeneca plc

9.3.3 Bayer AG

9.3.4 Boston Scientific Corporation

9.3.5 Eli Lilly and Company

9.3.6 Johnson & Johnson

9.3.7 Medtronic plc



10. About Us & Disclaimer